By 2040, one third of worldwide cases of age-related macular degeneration (AMD) will originate from Asia.1 Although both geographic atrophy (GA) and neovascular AMD (nAMD) can result in irreversible blindness, currently no treatment exists for GA. Thus, understanding the global epidemiologic characterists of GA can better guide allocations of health care resources and future research. To address the limited knowledge regarding the prevalence of GA in the Asian population, Rim et al2 (see page 1371) performed a cross-sectional meta-analysis of 22 population-based studies from the Asian Eye Epidemiology Consortium. A total of 97,213 individuals from 10 Asian countries were included.